Effect of suramin on the human pathogen Candida albicans: Implications on the fungal development and virulence

FEMS Immunology and Medical Microbiology

Volumn 51, Issue 2, 2007, Pages 399-406

  Braga Silva, Lys Adriana ^a   Souza Dos Santos, André Luis ^a   Portela, Maristela Barbosa ^a   Souto Padrón, Thaïs ^a   Soares, Rosangela Maria De Araújo ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Adhesion; Candida albicans; Germ tube; Growth; Suramin; Ultrastructure

Indexed keywords

SURAMIN; UREA DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CELL COUNT; CELL DIFFERENTIATION; CELL INTERACTION; CELL TRANSFORMATION; CELL VACUOLE; CELL WALL; CHILD; CYTOPLASM; DRUG EFFECT; DRUG MECHANISM; EPITHELIUM CELL; FEMALE; FUNGAL DEVELOPMENT; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; FUNGUS ISOLATION; GROWTH DISORDER; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; THICKNESS; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; YEAST; YEAST CELL;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CELL WALL; CHILD; CHILD, PRESCHOOL; EPITHELIAL CELLS; FEMALE; HUMANS; MALE; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON, TRANSMISSION; SURAMIN; VACUOLES;

EID: 35148852587     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00321.x     Document Type: Article

References (32)

1. Aperis G, Myrionis N, Spanakis EK Mylonakis E (2006) Developments in the treatment of candidiasis: more choices and new challenges. Expert Opin Invest Drugs 15 : 1319 1336.
2. Barrett SV Barrett MP (2000) Anti-sleeping sickness drugs and cancer chemotherapy. Parasitol Today 16 : 7 9.
3. Cadene M, Duranton J, North A, Si-tahar M, Chignard M Bieth JG (1997) Inhibition of neutrophil serine proteinases by suramin. J Biol Chem 272 : 9950 9955.
4. Casanova M, Cervera AM, Gozalbo D Martinez JP (1997) Hemin induces germ tube formation in Candida albicans. Infect Immun 65 : 4360 4364.
5. Castilla R, Passeron S Cantore ML (1998) N-acetyl-d-glucosamine induces germination in Candida albicans through a mechanism sensitive to inhibitors of cAMP-dependent protein kinase. Cell Signal 10 : 713 719.
6. Cirillo A, Chifflet S Villar B Neural retina of chick embryo in organ culture: effects of blockade of growth factors by suramin. Cell Tissue Res 304 : 323 331.
7. Constantopoulos G, Rees S, Cragg BG, Barranger JA Brady RO (1983) Suramin-induced storage disease. Mucopolysaccharidosis. Am J Pathol 113 : 266 268.
8. Costa EMMB, Santos ALS, Cardoso AS, Portela MB, Abreu CM, Alviano CS, Hagler NA Soares RMA (2003) Heterogeneity of metallo and serine proteinase in oral clinical isolates of Candida albicans in HIV-positive and healthy children from Rio de Janeiro, Brazil. FEMS Immunol Med Microbiol 38 : 173 180.
9. De Clerq E (1979) Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses. Cancer Lett 8 : 9 22.
10. Eggimann P, Garbino J Pittet D (2003) Management of Candida species infections in critically ill patients. Lancet Infect Dis 3 : 772 785.
11. Gschwendt M, Kittstein W Johannes FJ (1998) Differential effects of suramin on protein kinase C isoenzymes. A novel tool for discriminating protein kinase C activities. FEBS Lett 421 : 165 168.
12. Hauman CH, Thompson IO, Theunissen F Wolfaardt P (1993) Oral carriage of Candida in healthy and HIV-seropositive persons. Oral Surg Oral Med Oral Pathol 76 : 570 572.
13. Hazen KC Cutler JE (1979) Autoregulation of germ tube formation by Candida albicans. Infect Immun 24 : 661 666.
14. He X, Tiballi RN, Zarins LT, Bradley SF, Sangeorzan JA Kauffman CA (1994) Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 38 : 2495 2497.
15. Hilgers LA, Snippe H, Jansze M Willers JM (1985) Effect of in vivo administration of different adjuvants on the in vitro candidacidal activity of mouse peritoneal cells. Cell Immunol 90 : 14 23.
16. Kehinde EO, Terry TR, Mistry N, Horsburgh T, Sandhu DP Bell PR (1995) UK studies on suramin therapy in hormone resistant prostate cancer. Cancer Surv 23 : 217 229.
17. Kosarek CE, Hu X, Couto CG, Kisseberth WC, Green EM Au JL (2006) Phase I evaluation of low-dose suramin as chemosensitizer of doxorubicin in dogs with naturally occurring cancers. J Vet Intern Med 20 : 1172 1177.
18. Kumamoto CA Vinces MD (2005) Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence. Cell Microbiol 7 : 1546 1554.
19. Meyer-Fernandes JR (2002) Ecto-ATPases in protozoa parasites: looking for a function. Parasitol Int 51 : 299 303.
20. Naglik JR, Challacombe SJ Hube B (2003) Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 67 : 400 428.
21. Ohmori T, Yatomi Y, Okamoto H, Miura Y, Rile G, Satoh K Ozaki Y (2001) G(i)-mediated Cas tyrosine phosphorylation in vascular endothelial cells stimulated with sphingosine 1-phosphate: possible involvement in cell motility enhancement in cooperation with Rho-mediated pathways. J Biol Chem 76 : 5274 5280.
22. Olaechea PM, Palomar M, Leon-Gil C, Alvarez-Lerma F, Jorda R, Nolla-Salas J Leon-Regidor MA (2004) Epcan study Group. Economic impact of Candida colonization and Candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis 23 : 323 330.
23. Ostrosky-Zeichner L Pappas PG (2006) Invasive candidiasis in the intensive care unit. Crit Care Med 34 : 857 863.
24. Pfaller MA, Lockhart SR, Pujol C, Swails-Wenger JA, Messer SA, Edmond MB, Jones RN, Wenzel RP Soll DR (1998) Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates. Clin Microb 36 : 1518 1529.
25. Portela MB, Souza IPR, Costa EMMB, Hagler AN, Soares RMA Santos ALS (2004) Differential recovery of Candida species from subgingival sites in human immunodeficiency virus-positive and healthy children from Rio de Janeiro, Brazil. J Clin Microbiol 41 : 5925 5927.
26. Regmi A, Fuson T, Yang X, Kays J, Moxham C, Zartler E, Chandrashekhar S Galvin RJ (2005) Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiation. Bone 36 : 284 291.
27. Rentz AM, Halpern MT Bowden R (1998) The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 27 : 781 788.
28. Ruiz-Herrera J, Elorza MV, Valentim E Sentandreu R (2006) Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity. FEMS Yeast Res 6 : 14 29.
29. Stein CA, LaRocca RV, Thomas R, McAtee N Myers CE (1989) Suramin: an anticancer drug with a unique mechanism of action. J Clin Oncol 7 : 499 508.
30. Trinquier M, Perie J, Callens M, Opperdoes F Willson M (1995) Specific inhibitors for the glycolytic enzymes of Trypanosoma brucei. Bioorg Med Chem 3 : 1423 1427.
31. Voogd TE, Vansterkenburg EL, Wilting J Janssen LH (1993) Recent research on the biological activity of suramin. Pharmacol Rev 45 : 177 203.
32. Zhang YL, Keng YF, Zhao Y, Wu L Zhang ZY (1998) Suramin is an active site-directed, reversible, and tight-binding inhibitor of protein-tyrosine phosphatases. J Biol Chem 273 : 12281 12287.